Hospital
County of San Mateo
County of San Mateo was paid $75.66M by Medicaid between Jan 2018 and Dec 2024, across 574 billing codes. Its largest line is 0510, — 17% of everything it billed.
33Billing provider infoCOUNTY OF SAN MATEO
SAN MATEO, CA 94403
SAN MATEO, CA 94403
33aNPI1003985755assigned 11/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$75.66M
24GClaims3,295,107
24DCodes billed574
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#35 of 410
Median peer was paid$6.90M
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PAPA, JENNIFER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 475,399 | $10.76M | |
| 2019 | 460,972 | $10.23M | |
| 2020 | 301,762 | $6.37M | |
| 2021 | 404,525 | $8.72M | |
| 2022 | 489,091 | $11.30M | |
| 2023 | 566,824 | $13.35M | |
| 2024incomplete | 596,534 | $14.93M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0510 | 17% | 431,823 | 361,529 | $12.57M | |
| 0450 | Emergency room services | 7.4% | 92,514 | 80,946 | $5.59M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4.9% | 96,405 | 78,232 | $3.73M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.7% | 24,679 | 22,552 | $3.56M |
| Z7502 | 2.7% | 55,257 | 54,606 | $2.05M | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 2.0% | 1,204 | 1,195 | $1.49M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.9% | 17,547 | 17,435 | $1.46M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 11,210 | 10,189 | $1.32M |
| 80053 | Comprehensive metabolic panel | 1.7% | 144,572 | 137,423 | $1.29M |
| 86480 | 1.5% | 24,401 | 24,165 | $1.14M | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.5% | 49,314 | 48,120 | $1.13M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.5% | 49,322 | 48,128 | $1.12M |
562 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 5,619 | $1.11M |
| 0360 | 1.3% | 9,464 | $966K | |
| 90750 | 1.2% | 6,964 | $944K | |
| 97139 | 1.1% | 45,481 | $849K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 5,436 | $844K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 69,739 | $836K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 112,806 | $802K |
| 80061 | Lipid panel | 1.0% | 87,996 | $786K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 31,967 | $776K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 11,069 | $751K |
| 90677 | <1% | 4,442 | $719K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 102,846 | $683K |
| 90686 | <1% | 35,688 | $677K | |
| 90715 | <1% | 17,109 | $671K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 33,508 | $629K |
| 0225U | <1% | 1,945 | $615K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,306 | $607K |
| 0750 | <1% | 4,693 | $587K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 100,688 | $546K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 27,091 | $512K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,547 | $479K |
| 90651 | <1% | 7,539 | $460K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,121 | $423K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 5,090 | $376K |
| 90739 | <1% | 1,754 | $341K | |
| 97750 | <1% | 7,933 | $335K | |
| J3490 | Unclassified drugs | <1% | 31,101 | $329K |
| 99284 | Emergency room visit (serious) | <1% | 5,973 | $317K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 1,660 | $316K |
| Z7610 | <1% | 38,570 | $311K | |
| 76641 | <1% | 3,740 | $299K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 9,762 | $299K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 15,535 | $296K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13,398 | $282K |
| 90746 | <1% | 4,652 | $268K | |
| 90679 | <1% | 797 | $265K | |
| 77066 | Tomosynthesis, mammo | <1% | 2,345 | $260K |
| 97799 | <1% | 13,398 | $259K | |
| 77065 | Tomosynthesis, mammo | <1% | 3,025 | $258K |
| 0900 | <1% | 8,993 | $257K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 215 | $255K |
| 82274 | <1% | 22,400 | $247K | |
| 90688 | <1% | 12,670 | $247K | |
| 0710 | <1% | 10,727 | $242K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 4,820 | $238K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 1,452 | $236K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,664 | $234K |
| 99070 | <1% | 95,727 | $232K | |
| 85027 | <1% | 45,085 | $222K | |
| 86803 | <1% | 18,817 | $219K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,798 | $216K |
| 81025 | <1% | 35,566 | $210K | |
| 87536 | <1% | 3,638 | $204K | |
| G9920 | Screening performed and negative | <1% | 5,801 | $200K |
| 86780 | <1% | 18,880 | $199K | |
| 80074 | <1% | 5,392 | $197K | |
| 76830 | Ultrasound, transvaginal | <1% | 3,449 | $197K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 3,177 | $195K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,920 | $189K |
| 90682 | <1% | 6,497 | $186K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 29,250 | $181K |
| 90716 | <1% | 4,432 | $178K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,109 | $175K |
| 87631 | <1% | 2,885 | $172K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,772 | $171K |
| 90670 | <1% | 2,961 | $167K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 5,228 | $161K |
| 96156 | <1% | 1,759 | $156K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 2,699 | $156K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,764 | $156K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,428 | $153K |
| 83690 | <1% | 16,835 | $152K | |
| 73221 | <1% | 905 | $151K | |
| 81003 | <1% | 67,537 | $150K | |
| 99283 | Emergency room visit (moderate) | <1% | 4,365 | $145K |
| 84484 | <1% | 10,962 | $145K | |
| 96158 | <1% | 2,480 | $143K | |
| 71250 | <1% | 1,319 | $124K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 5,527 | $124K |
| 20610 | <1% | 5,353 | $123K | |
| 92552 | <1% | 6,520 | $123K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 13,543 | $117K |
| 76770 | <1% | 2,089 | $115K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,306 | $113K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 699 | $113K |
| 97165 | <1% | 2,977 | $111K | |
| 0352U | <1% | 972 | $108K | |
| 86003 | <1% | 1,776 | $108K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 17,112 | $105K |
| 90707 | <1% | 2,780 | $103K | |
| 0012A | <1% | 3,445 | $102K | |
| 96112 | <1% | 2,558 | $99K | |
| 86706 | <1% | 11,089 | $98K | |
| 73630 | <1% | 4,365 | $97K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,253 | $96K |
| 82043 | <1% | 26,689 | $96K | |
| 82570 | <1% | 29,212 | $96K | |
| 87340 | <1% | 11,094 | $94K | |
| 82948 | <1% | 38,301 | $94K | |
| 84439 | <1% | 14,651 | $92K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 3,912 | $92K |
| 76536 | <1% | 1,905 | $89K | |
| 93017 | <1% | 1,545 | $89K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 6,261 | $85K |
| J0897 | Injection, denosumab, 1 mg | <1% | 70 | $84K |
| 93226 | <1% | 1,556 | $82K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 455 | $82K |
| 83880 | <1% | 3,856 | $82K | |
| 96415 | <1% | 2,387 | $82K | |
| 93971 | <1% | 916 | $80K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,607 | $79K |
| 83970 | <1% | 3,409 | $79K | |
| 84153 | <1% | 6,533 | $79K | |
| 86360 | <1% | 2,587 | $78K | |
| 73610 | <1% | 3,238 | $78K | |
| 90649 | <1% | 837 | $77K | |
| 87653 | <1% | 2,590 | $75K | |
| 0002A | <1% | 2,477 | $74K | |
| 83550 | <1% | 13,966 | $74K | |
| 87557 | <1% | 1,674 | $73K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 11,737 | $73K |
| 93351 | <1% | 657 | $73K | |
| 82728 | <1% | 8,898 | $73K | |
| 92557 | <1% | 1,272 | $72K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 3,320 | $72K |
| 73110 | <1% | 2,902 | $71K | |
| 11721 | <1% | 7,918 | $71K | |
| 71045 | Radiologic examination, chest; single view | <1% | 6,844 | $70K |
| 84403 | <1% | 3,332 | $68K | |
| 90678 | <1% | 194 | $68K | |
| 94060 | <1% | 2,017 | $66K | |
| 90633 | <1% | 5,715 | $65K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 2,229 | $65K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 619 | $65K |
| 73030 | <1% | 2,971 | $65K | |
| 83540 | <1% | 14,848 | $64K | |
| 73564 | <1% | 3,799 | $64K | |
| 87088 | <1% | 11,613 | $62K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,291 | $62K |
| 73130 | <1% | 2,486 | $61K | |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 50 | $60K |
| 87581 | <1% | 1,184 | $59K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 2,766 | $59K |
| 87486 | <1% | 1,183 | $59K | |
| 72100 | <1% | 2,494 | $58K | |
| 0001A | <1% | 2,863 | $58K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,216 | $58K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 1,543 | $58K |
| 0011A | <1% | 3,353 | $58K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 731 | $57K |
| 86762 | <1% | 4,539 | $56K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 183 | $56K |
| 93225 | <1% | 1,860 | $55K | |
| 94726 | <1% | 1,478 | $55K | |
| 0072A | <1% | 1,325 | $53K | |
| 80076 | <1% | 9,651 | $53K | |
| 90662 | <1% | 1,868 | $53K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,743 | $52K |
| 86787 | <1% | 4,712 | $52K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 766 | $51K |
| 70486 | <1% | 351 | $51K | |
| 52000 | <1% | 1,056 | $51K | |
| 0071A | <1% | 1,269 | $50K | |
| 92083 | <1% | 4,540 | $50K | |
| 86235 | <1% | 616 | $49K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 9,866 | $49K |
| 87040 | <1% | 2,406 | $48K | |
| 90736 | <1% | 201 | $48K | |
| 76642 | <1% | 826 | $48K | |
| 99285 | Emergency room visit (most serious) | <1% | 626 | $47K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 9,118 | $47K |
| 86704 | <1% | 4,655 | $46K | |
| 83655 | <1% | 5,211 | $46K | |
| 73560 | <1% | 2,649 | $46K | |
| 83735 | <1% | 7,089 | $45K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,290 | $45K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 213 | $44K |
| 81001 | <1% | 12,457 | $44K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,923 | $43K |
| 90744 | <1% | 3,787 | $43K | |
| 85610 | <1% | 15,270 | $43K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,988 | $42K |
| 90714 | <1% | 1,700 | $41K | |
| 96127 | <1% | 7,612 | $41K | |
| 82105 | <1% | 3,130 | $41K | |
| 0004A | <1% | 1,132 | $39K | |
| 86140 | <1% | 9,326 | $39K | |
| 76857 | <1% | 2,431 | $39K | |
| 94729 | <1% | 1,536 | $38K | |
| 87517 | <1% | 1,358 | $38K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,004 | $37K |
| 82746 | <1% | 4,269 | $37K | |
| 90698 | <1% | 3,226 | $37K | |
| 11056 | <1% | 2,440 | $37K | |
| 87522 | Neg quan hep c or qual rna | <1% | 1,243 | $36K |
| 87506 | <1% | 168 | $34K | |
| 72141 | <1% | 190 | $34K | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,991 | $33K |
| 83605 | <1% | 2,300 | $33K | |
| 92595 | <1% | 622 | $33K | |
| 92133 | <1% | 2,881 | $32K | |
| 0762 | <1% | 182 | $32K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,721 | $31K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 650 | $29K |
| 87081 | <1% | 5,076 | $29K | |
| 76870 | <1% | 585 | $29K | |
| 92567 | <1% | 913 | $29K | |
| 87186 | <1% | 3,991 | $28K | |
| 73523 | <1% | 749 | $28K | |
| 90734 | <1% | 2,452 | $28K | |
| 85007 | <1% | 10,422 | $28K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 4,367 | $27K |
| 84481 | <1% | 2,289 | $27K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,106 | $27K |
| 82785 | <1% | 1,675 | $26K | |
| 83001 | <1% | 1,675 | $26K | |
| 90713 | <1% | 1,824 | $26K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 4,698 | $25K |
| 85018 | <1% | 11,654 | $25K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 1,238 | $25K |
| 84146 | <1% | 1,567 | $24K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,156 | $24K |
| 86038 | <1% | 3,405 | $24K | |
| 76801 | <1% | 406 | $24K | |
| 87070 | <1% | 2,880 | $24K | |
| 90710 | <1% | 1,982 | $23K | |
| 90480 | <1% | 1,495 | $23K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 2,057 | $23K |
| 85730 | <1% | 3,810 | $22K | |
| 93350 | <1% | 427 | $22K | |
| 84402 | <1% | 1,045 | $22K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,935 | $21K |
| 73080 | <1% | 846 | $21K | |
| 90696 | <1% | 1,857 | $21K | |
| 85379 | <1% | 1,604 | $21K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,169 | $21K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 107 | $20K |
| 74018 | <1% | 1,104 | $20K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 2,916 | $20K |
| 96417 | <1% | 589 | $20K | |
| 87507 | <1% | 59 | $20K | |
| 90656 | <1% | 991 | $20K | |
| 86850 | <1% | 4,867 | $19K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 532 | $19K |
| 86709 | <1% | 2,170 | $19K | |
| 83516 | <1% | 2,304 | $19K | |
| 84460 | <1% | 4,487 | $19K | |
| 73502 | <1% | 836 | $19K | |
| 87210 | <1% | 4,374 | $19K | |
| 82607 | <1% | 4,607 | $19K | |
| 31575 | <1% | 592 | $19K | |
| 74150 | <1% | 92 | $18K | |
| 82565 | <1% | 5,227 | $18K | |
| 86901 | <1% | 5,454 | $18K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 623 | $18K |
| 97161 | <1% | 662 | $17K | |
| 11055 | <1% | 1,278 | $17K | |
| 82670 | <1% | 961 | $17K | |
| 84702 | <1% | 1,131 | $16K | |
| 82947 | <1% | 5,358 | $16K | |
| 73620 | <1% | 706 | $16K | |
| 90619 | <1% | 1,345 | $16K | |
| 73140 | <1% | 958 | $16K | |
| 82378 | <1% | 1,174 | $15K | |
| 84450 | <1% | 3,605 | $15K | |
| 81002 | <1% | 7,131 | $15K | |
| 86318 | <1% | 771 | $15K | |
| 82550 | <1% | 2,523 | $15K | |
| 86765 | <1% | 1,291 | $15K | |
| 43235 | <1% | 532 | $15K | |
| 70498 | <1% | 81 | $15K | |
| 90685 | <1% | 1,326 | $15K | |
| 84550 | <1% | 4,765 | $15K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 544 | $15K |
| 80069 | <1% | 2,973 | $14K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 510 | $14K |
| 99401 | <1% | 845 | $14K | |
| 90732 | <1% | 445 | $14K | |
| 86255 | <1% | 1,203 | $14K | |
| 82950 | <1% | 3,422 | $14K | |
| 88720 | <1% | 2,712 | $14K | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 1,373 | $14K |
| 88342 | <1% | 960 | $14K | |
| 86900 | <1% | 5,035 | $13K | |
| 96111 | <1% | 453 | $13K | |
| 0064A | <1% | 437 | $13K | |
| 86735 | <1% | 1,116 | $12K | |
| 82977 | <1% | 2,205 | $12K | |
| 11981 | <1% | 677 | $12K | |
| 0124A | <1% | 1,415 | $11K | |
| 86705 | <1% | 1,186 | $11K | |
| 83002 | <1% | 734 | $11K | |
| 70543 | <1% | 39 | $11K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 217 | $11K |
| 86593 | <1% | 2,974 | $11K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,192 | $10K |
| 90733 | <1% | 724 | $10K | |
| 87209 | <1% | 1,015 | $10K | |
| 90658 | <1% | 361 | $10K | |
| 90681 | <1% | 822 | $10K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,185 | $10K |
| 73562 | <1% | 487 | $10K | |
| 82784 | <1% | 1,655 | $10K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 151 | $9K |
| 83883 | <1% | 1,021 | $9K | |
| 86225 | <1% | 1,021 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 46,903 | $9K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 367 | $9K |
| 92134 | <1% | 773 | $9K | |
| 20550 | <1% | 1,016 | $9K | |
| 69209 | <1% | 1,117 | $9K | |
| 11720 | <1% | 1,552 | $8K | |
| 92015 | Determination of refractive state | <1% | 1,243 | $8K |
| 86039 | <1% | 1,078 | $8K | |
| 84165 | <1% | 1,266 | $8K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,297 | $8K |
| 74170 | <1% | 38 | $8K | |
| 86376 | <1% | 627 | $8K | |
| 87529 | <1% | 268 | $8K | |
| 86430 | <1% | 1,650 | $7K | |
| 11982 | <1% | 413 | $7K | |
| 83525 | <1% | 740 | $7K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,278 | $7K |
| 82627 | <1% | 393 | $7K | |
| 58300 | <1% | 972 | $7K | |
| 51798 | <1% | 594 | $7K | |
| 11750 | <1% | 277 | $7K | |
| 96132 | <1% | 130 | $7K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 906 | $7K |
| 87045 | <1% | 865 | $7K | |
| 82951 | <1% | 609 | $7K | |
| 87149 | <1% | 668 | $7K | |
| 84100 | <1% | 2,186 | $7K | |
| 87177 | <1% | 1,019 | $6K | |
| 85651 | <1% | 2,514 | $6K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,688 | $6K |
| 87799 | <1% | 210 | $6K | |
| 72052 | <1% | 164 | $6K | |
| 85652 | <1% | 2,776 | $6K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,180 | $6K |
| 84156 | <1% | 2,473 | $6K | |
| 82248 | <1% | 1,559 | $6K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 335 | $6K |
| 83498 | <1% | 242 | $6K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 834 | $6K |
| 83721 | <1% | 788 | $5K | |
| 69210 | <1% | 809 | $5K | |
| 70496 | <1% | 29 | $5K | |
| 72020 | <1% | 479 | $5K | |
| 82330 | <1% | 656 | $5K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,401 | $5K |
| 20553 | <1% | 388 | $5K | |
| 11765 | <1% | 238 | $5K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 260 | $5K |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 347 | $5K |
| 71020 | <1% | 201 | $5K | |
| 91320 | <1% | 1,057 | $5K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 95 | $5K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 140 | $5K |
| 83010 | <1% | 527 | $5K | |
| 83615 | <1% | 1,071 | $5K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 359 | $4K |
| 72072 | <1% | 158 | $4K | |
| 85045 | <1% | 1,503 | $4K | |
| 90700 | <1% | 378 | $4K | |
| 87116 | <1% | 709 | $4K | |
| 58100 | <1% | 141 | $4K | |
| 98967 | <1% | 706 | $4K | |
| 64483 | <1% | 88 | $4K | |
| 82310 | <1% | 1,201 | $4K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 629 | $4K |
| V5010 | Assessment for hearing aid | <1% | 59 | $4K |
| 97003 | <1% | 99 | $4K | |
| 83993 | <1% | 234 | $4K | |
| 84445 | <1% | 94 | $4K | |
| 82172 | <1% | 335 | $4K | |
| 47562 | <1% | 12 | $4K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 671 | $4K |
| 82533 | <1% | 299 | $4K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 231 | $3K |
| 90632 | <1% | 55 | $3K | |
| 86200 | <1% | 535 | $3K | |
| 11100 | <1% | 223 | $3K | |
| 71101 | <1% | 83 | $3K | |
| 10060 | <1% | 162 | $3K | |
| 85014 | <1% | 1,600 | $3K | |
| 97162 | <1% | 163 | $3K | |
| 87077 | <1% | 723 | $3K | |
| 87338 | <1% | 769 | $3K | |
| 0112A | <1% | 69 | $3K | |
| 17110 | <1% | 535 | $3K | |
| 58301 | <1% | 430 | $3K | |
| 70491 | <1% | 14 | $3K | |
| 82009 | <1% | 499 | $3K | |
| 95909 | <1% | 52 | $3K | |
| 87641 | <1% | 96 | $3K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 75 | $3K |
| 96116 | <1% | 94 | $3K | |
| 95886 | <1% | 51 | $3K | |
| 0513 | Prolong prev svcs, addl 30m | <1% | 95 | $3K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 12 | $2K |
| 70320 | <1% | 83 | $2K | |
| 87015 | <1% | 480 | $2K | |
| 86364 | <1% | 179 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 310 | $2K |
| 74178 | <1% | 12 | $2K | |
| 73590 | <1% | 122 | $2K | |
| 94375 | <1% | 134 | $2K | |
| 99199 | Unlisted special service, procedure or report | <1% | 47 | $2K |
| 0003A | <1% | 56 | $2K | |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | <1% | 23 | $2K |
| 73503 | <1% | 54 | $2K | |
| 92132 | <1% | 169 | $2K | |
| 87520 | <1% | 112 | $2K | |
| 0918 | <1% | 66 | $2K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,042 | $2K |
| 86015 | <1% | 153 | $2K | |
| 87206 | <1% | 441 | $2K | |
| 84132 | <1% | 765 | $2K | |
| 73660 | <1% | 131 | $2K | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 281 | $2K |
| 11900 | <1% | 297 | $2K | |
| 90674 | <1% | 160 | $2K | |
| 82150 | <1% | 346 | $2K | |
| 86334 | <1% | 119 | $2K | |
| 94644 | <1% | 75 | $2K | |
| 93296 | <1% | 61 | $2K | |
| 92002 | <1% | 90 | $2K | |
| 82390 | <1% | 181 | $2K | |
| 0915 | <1% | 54 | $2K | |
| 87807 | <1% | 187 | $2K | |
| 86381 | <1% | 132 | $1K | |
| 31231 | <1% | 123 | $1K | |
| 82952 | <1% | 428 | $1K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 320 | $1K |
| 74019 | <1% | 67 | $1K | |
| 0013A | <1% | 35 | $1K | |
| 84425 | <1% | 95 | $1K | |
| 82803 | <1% | 52 | $1K | |
| 00142 | <1% | 12 | $1K | |
| 29125 | <1% | 193 | $1K | |
| J1815 | Injection, insulin, per 5 units | <1% | 161 | $1K |
| 86160 | <1% | 81 | $1K | |
| 0054A | <1% | 429 | $1K | |
| 90648 | <1% | 111 | $1K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 24 | $1K |
| 0074A | <1% | 27 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 6,457 | $1K |
| 83986 | <1% | 347 | $1K | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 203 | $1K |
| 87328 | <1% | 124 | $1K | |
| 83021 | <1% | 95 | $1K | |
| 92250 | <1% | 148 | $1K | |
| 0154A | <1% | 25 | $1K | |
| 29580 | <1% | 112 | $922.83 | |
| 92136 | <1% | 29 | $911.64 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 376 | $909.60 |
| 84300 | <1% | 306 | $906.20 | |
| 87329 | <1% | 124 | $879.12 | |
| 90620 | <1% | 69 | $875.34 | |
| 86696 | <1% | 82 | $861.16 | |
| 11983 | <1% | 53 | $861.00 | |
| 82103 | <1% | 71 | $748.54 | |
| 86695 | <1% | 82 | $748.16 | |
| 86708 | <1% | 70 | $737.12 | |
| 98968 | <1% | 118 | $736.44 | |
| 80164 | <1% | 81 | $735.63 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 60 | $734.39 |
| 86308 | <1% | 124 | $713.83 | |
| 11730 | <1% | 66 | $701.10 | |
| 96150 | <1% | 61 | $693.17 | |
| 82340 | <1% | 148 | $688.43 | |
| 90381 | <1% | 61 | $675.27 | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 30 | $674.45 |
| 73090 | <1% | 40 | $666.62 | |
| 86580 | <1% | 157 | $664.49 | |
| 82507 | <1% | 29 | $656.64 | |
| 12001 | <1% | 40 | $590.40 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 66 | $487.75 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 20 | $477.68 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 79 | $452.32 |
| 76942 | <1% | 16 | $450.83 | |
| 97803 | <1% | 32 | $449.31 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 27 | $414.20 |
| 96523 | <1% | 15 | $401.22 | |
| S4993 | Contraceptive pills for birth control | <1% | 27 | $390.89 |
| 72040 | <1% | 20 | $388.96 | |
| 98966 | <1% | 142 | $384.03 | |
| 51701 | <1% | 27 | $383.77 | |
| 87449 | <1% | 46 | $374.66 | |
| 87427 | <1% | 46 | $342.86 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $329.64 |
| 20600 | <1% | 13 | $325.22 | |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 19 | $309.27 |
| 83945 | <1% | 29 | $307.26 | |
| 11057 | <1% | 28 | $284.43 | |
| 84145 | <1% | 13 | $284.18 | |
| 87205 | <1% | 65 | $283.01 | |
| 17000 | <1% | 39 | $275.19 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 36 | $274.84 |
| 86812 | <1% | 12 | $270.84 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 1,174 | $266.45 |
| 99195 | <1% | 16 | $264.95 | |
| 85246 | <1% | 12 | $240.72 | |
| 86665 | <1% | 13 | $240.50 | |
| J1836 | Injection, metronidazole, 10 mg | <1% | 29 | $231.78 |
| 86682 | <1% | 24 | $227.60 | |
| 82247 | <1% | 71 | $225.12 | |
| 29515 | <1% | 30 | $220.14 | |
| 97116 | <1% | 66 | $206.40 | |
| 80051 | <1% | 38 | $197.39 | |
| 83921 | <1% | 25 | $187.72 | |
| 84133 | <1% | 56 | $180.48 | |
| 90673 | <1% | 37 | $175.78 | |
| 83695 | <1% | 16 | $169.95 | |
| 93280 | <1% | 15 | $149.85 | |
| 82465 | <1% | 43 | $137.88 | |
| 46600 | <1% | 12 | $135.30 | |
| 84703 | <1% | 12 | $132.10 | |
| 76882 | <1% | 12 | $129.58 | |
| 84166 | <1% | 12 | $124.80 | |
| 94664 | <1% | 32 | $123.10 | |
| 84105 | <1% | 29 | $122.85 | |
| 86664 | <1% | 13 | $120.25 | |
| 87147 | <1% | 32 | $119.35 | |
| 84392 | <1% | 29 | $116.64 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 142 | $114.54 |
| 84560 | <1% | 29 | $112.32 | |
| 84520 | <1% | 37 | $111.60 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,727 | $108.48 |
| G0009 | Administration of pneumococcal vaccine | <1% | 1,314 | $105.70 |
| 89055 | <1% | 27 | $98.91 | |
| 97810 | <1% | 12 | $85.44 | |
| 97124 | <1% | 27 | $70.90 | |
| 76514 | <1% | 13 | $58.24 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 24 | $57.01 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 15 | $54.55 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 405 | $47.76 |
| 0270 | <1% | 23 | $46.99 | |
| 80178 | <1% | 13 | $37.40 | |
| 91319 | <1% | 38 | $27.00 | |
| 83935 | <1% | 14 | $26.80 | |
| 81050 | <1% | 13 | $20.76 | |
| 84155 | <1% | 12 | $17.52 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 99 | $12.00 |
| A6446 | Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard | <1% | 26 | $11.25 |
| 94761 | <1% | 47 | $7.50 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 17 | $5.97 |
| A9270 | Non-covered item or service | <1% | 6,397 | $4.54 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 212 | $0.16 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 58 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 79 | $0.00 |
| 91305 | 0% | 363 | $0.00 | |
| 91306 | 0% | 112 | $0.00 | |
| 88142 | 0% | 34 | $0.00 | |
| G0010 | Administration of hepatitis b vaccine | 0% | 39 | $0.00 |
| 91300 | 0% | 124 | $0.00 | |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 105 | $0.00 |
| J1240 | Injection, dimenhydrinate, up to 50 mg | 0% | 13 | $0.00 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 83 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 257 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPAPA, JENNIFER (CHIEF FINANCIAL OFFICER)
Parent organizationCOUNTY OF SAN MATEO
| Provider | Location | Paid |
|---|---|---|
| County of San Mateo | San Mateo, CA | $66.31M |
| County of San Mateo | Redwood City, CA | $53.69M |
| County of San Mateo | Daly City, CA | $23.37M |
| County of San Mateo | San Mateo, CA | $17.99M |
| County of San Mateo | San Mateo, CA | $10.95M |
| County of San Mateo | San Mateo, CA | $8.87M |
| County of San Mateo | South San Francisco, CA | $8.31M |
| County of San Mateo | Half Moon Bay, CA | $7.33M |
| County of San Mateo | San Mateo, CA | $3.32M |
| County of San Mateo | Redwood City, CA | $3.21M |
| County of San Mateo | Daly City, CA | $1.61M |
| San Mateo County Aging & Disability Services | San Mateo, CA | $784K |
| County of San Mateo | San Mateo, CA | $720K |
| County of San Mateo | San Mateo, CA | $190K |
| County of San Mateo | San Mateo, CA | $136K |
| San Mateo County | San Mateo, CA | $88K |
| San Mateo County California Children's Services | San Mateo, CA | $55K |
| San Mateo Medical Center | Daly City, CA | $41K |
| County of San Mateo | San Bruno, CA | $25K |
| San Mateo Medical Center | San Mateo, CA | $9K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.